08 Nov 2022 --- Sibelius Natural Products has secured a grant from the Balvi philanthropic fund to further develop its Sibelius: Chamomile product – a Roman chamomile extract – to alleviate Long COVID symptoms. The funding will allow Sibelius to collaborate with researchers from the University of Buckingham to demonstrate the product’s anti-inflammatory qualities.“The grant from the Balvi philanthropic fund will allow Sibelius to bring forward plans to test the Sibelius: Chamomile extract ingredient in a clinical setting,” Dr. Kieron Edwards, chief scientific officer at Sibelius, tells NutritionInsight.
